STUDY PURPOSE: This observational study describes the three-year survival outcome of consecutively recruited advanced stage breast, colorectal, ovarian and pancreatic cancer patients receiving advanced integrative oncology (AIO) treatment at one of...
Welcome to the Bastyr Clinical Outcomes Study! We are conducting medical outcomes research and we would like you to participate by completing an online questionnaire about you and your health. We are asking people with cancer to participate by...
This observational study seeks to describe the outcomes for individuals who choose to receive integrative oncology care. We will report on clinical outcomes of our patients in terms of whether cancer comes back after treatment (recurrence rates) and...
HYPOTHESIS: IO services improve patients' quality of life and decrease cancer recurrence rates in breast cancer patients as compared to women with similar disease states and prognoses who do not receive IO care, and may or may not use CAM treatment...
This study has merged into the BOS study. Please click here to be taken to the BOS study page for details and information on how to participate.  
Bastyr Integrative Oncolgy Reserch Center (BIORC) is actively recruiting participants with colon cancer at any stage to take part in an observational research study. By studying how cancer reacts when treated with naturopathic medicine, traditional...
  BACKGROUND: Although the Women's Health Initiative (WHI) trial of estrogen plus progestin in postmenopausal women identified more overall health risks than benefits among women in the hormone group, the use of estrogen plus progestin was...
  BACKGROUND: Insurance coverage of complementary and alternative medicine (CAM) is expanding. However, to the authors' knowledge, little is know concerning CAM utilization among cancer patients under the insurance model of financing. In this study...
This article reviews the evidence that the functioning of both the innate and the adaptive immune system plays a role in preventing relapse in women with breast cancer. Lymphocytes, including T cells, T regulatory cells, and natural killer cells,...
Data from multiple epidemiologic and clinical studies on immune effects of conventional cancer treatment and the clinical benefits of polysaccharide immune therapy suggest that immune function has a role in breast cancer prevention. Immune therapy...